Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Revenues $ 66 $ 691 $ 132 $ 15,191
Cost of revenues 43 429 74 1,315
Gross Profit 23 262 58 13,876
Operating expenses:        
Research and development 2,599 1,901 4,841 3,534
General, administrative and marketing 1,609 1,424 3,170 3,379
Operating income (loss) (4,185) (3,063) (7,953) 6,963
Financial income (expenses), net (100) 25 (192) 123
Net income (loss) for the period $ (4,285) $ (3,038) $ (8,145) $ 7,086
Basic net income (loss) per ordinary share (in Dollars per share) $ (0.39) $ (0.3) $ (0.74) $ 0.76
Diluted net income (loss) per ordinary share (in Dollars per share) $ (0.39) $ (0.3) $ (0.74) $ 0.58
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares) 11,086,481 10,201,231 10,935,611 9,315,817
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares) 11,086,481 10,201,231 10,935,611 12,173,715